California Public Employees Retirement System
LCTX icon

California Public Employees Retirement System’s Lineage Cell Therapeutics LCTX Stock Holding History

California Public Employees Retirement System’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-48,400
Closed -$114K – 2283
2021
Q1 		$114K Hold
48,400
– – ﹤0.01% 3451
2020
Q4 		$85K Hold
48,400
– – ﹤0.01% 3495
2020
Q3 		$45K Hold
48,400
– – ﹤0.01% 3477
2020
Q2 		$42K Hold
48,400
– – ﹤0.01% 3429
2020
Q1 		$40K Hold
48,400
– – ﹤0.01% 3281
2019
Q4 		$43K Hold
48,400
– – ﹤0.01% 3367
2019
Q3 		$47K Hold
48,400
– – ﹤0.01% 3184
2019
Q2 		$53K Hold
48,400
– – ﹤0.01% 3176
2019
Q1 		$63K Hold
48,400
– – ﹤0.01% 3111
2018
Q4 		$44K Sell
48,400
-6,921
-13% -$10.6K ﹤0.01% 3164
2018
Q3 		$114K Hold
55,321
– – ﹤0.01% 3136
2018
Q2 		$100K Hold
55,321
– – ﹤0.01% 3163
2018
Q1 		$130K Hold
55,321
– – ﹤0.01% 3084
2017
Q4 		$104K Hold
55,321
– – ﹤0.01% 3134
2017
Q3 		$137K Hold
55,321
– – ﹤0.01% 3096
2017
Q2 		$152K Hold
55,321
– – ﹤0.01% 3078
2017
Q1 		$167K Sell
55,321
-2,401
-4% -$6.82K ﹤0.01% 3083
2016
Q4 		$182K Hold
57,722
– – ﹤0.01% 3081
2016
Q3 		$197K Sell
57,722
-4,000
-6% -$11.1K ﹤0.01% 3099
2016
Q2 		$141K Sell
61,722
-1,943
-3% -$4.76K ﹤0.01% 3237
2016
Q1 		$160K Sell
63,665
-9,561
-13% -$21.3K ﹤0.01% 3220
2015
Q4 		$242K Hold
73,226
– – ﹤0.01% 3118
2015
Q3 		$177K Hold
73,226
– – ﹤0.01% 3259
2015
Q2 		$215K Hold
73,226
– – ﹤0.01% 3251
2015
Q1 		$246K Hold
73,226
– – ﹤0.01% 3328
2014
Q4 		$246K Hold
73,226
– – ﹤0.01% 3328
2014
Q3 		$186K Hold
73,226
– – ﹤0.01% 3423
2014
Q2 		$180K Hold
73,226
– – ﹤0.01% 3458
2014
Q1 		$184K Hold
73,226
– – ﹤0.01% 3420
2013
Q4 		$209K Sell
73,226
-2,106
-3% -$6.36K ﹤0.01% 3305
2013
Q3 		$231K Buy
75,332
+12,886
+21% +$40.8K ﹤0.01% 3119
2013
Q2 		$200K Buy
+62,446
New +$200K ﹤0.01% 3106

Other funds holding LCTX

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.96B AUM 58.65% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

California Public Employees Retirement System's LCTX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Lineage Cell Therapeutics (LCTX) in Q2 2021, closing a stake of 48,400 shares — an estimated $114K sold.

California Public Employees Retirement System first reported a position in LCTX in Q2 2013 and held it in 32 quarters. The position peaked at $246K in Q1 2015. 115 funds tracked by Wall St. Rank hold LCTX as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Lineage Cell Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 48,400 Lineage Cell Therapeutics shares in Q2 2021, an estimated $114K.
  • California Public Employees Retirement System first reported a position in Lineage Cell Therapeutics in Q2 2013 and held it in 32 quarters.
  • California Public Employees Retirement System's Lineage Cell Therapeutics position peaked at $246K in Q1 2015.
  • 115 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.